CPLX — what changed in the latest 10-Q
A section-by-section comparison of CPLX's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-17 vs the prior 10-Q · 2026-06-03
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +21 | −19 | ~3 | 14 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 1 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 0 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-17
The Company also holds licensing rights and continues to evaluate opportunities to generate revenue from those rights.
Cost of sales decreased to $5,495 for the three months ended June 30, 2026 from $6,643 for the three months ended June 30, 2025, a decrease of $1,148. For the six months ended June 30, 2026, cost of sales was $9,737, compared to $11,825 for the six months ended June 30, 2025, a decrease of $2,088. T…
Gross profit decreased to $20,343 for the three months ended June 30, 2026 from $33,118 for the three months ended June 30, 2025, a decrease of $12,775. Gross profit for the six months ended June 30, 2026 was $31,874, compared to $57,291 for the six months ended June 30, 2025, a decrease of $25,417.…
Total operating expenses decreased to $38,768 for the three months ended June 30, 2026 compared to $44,416 for the three months ended June 30, 2025, a decrease of $5,648. For the six months ended June 30, 2026, total operating expenses were $57,809, compared to $79,362 for the six months ended June …
• General and administrative expenses decreased to $1,930 from $10,447 for the three-month period and to $8,313 from $21,265 for the six-month period;
Text removed vs the prior filing · source: 10-Q · 2026-06-03
The Company also holds licensing rights; however, no licensing revenue was recognized during the three months ended March 31, 2026 or 2025.
Cost of sales decreased to $4,323 for the three months ended March 31, 2026 from $5,182 for the three months ended March 31, 2025, a decrease of $859. The 2026 amount includes $80 of resale product purchases. The overall decrease was generally consistent with the decline in revenue.
Gross profit decreased to $11,451 for the three months ended March 31, 2026 from $24,173 for the three months ended March 31, 2025. The decrease of $12,722 was primarily due to lower revenue.
Total operating expenses decreased to $18,961 for the three months ended March 31, 2026 compared to $34,946 for the three months ended March 31, 2025, a decrease of $15,985.
·General and administrative expenses decreased to $6,383 from $10,818;
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice